TripleBar Bio, Inc.
AI platform for genomic design automation that uses evolutionary algorithms to enable protein and organism design
- Sector
- Biotech
- Headquarters
- EMERYVILLE, CA
- Founded
- 2019
- Latest Form D
- $19.8M, Oct 2023
- Total capital
- $19.8M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $19.8M
- 1 Form D · last Oct 2023
- 36 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 6 pending · first 2024
- Rank in peer group#8 of 55
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$19.8M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 55 peers
Line = medianBiotech · Software
- Granted patents#8 · top 15%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- David FriedbergDirectorNamed in SEC Form D filings
- Howard LevinDirectorNamed in SEC Form D filings
- Maria ChoExecutive Officer, DirectorNamed in SEC Form D filings
- Rose WardleDirectorNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 8- PendingMultiparametric Discovery And Optimization PlatformUSPTOApplication 18864951
- PendingMultiparametric Discovery And Optimization PlatformUSPTOApplication 18617186
- GrantedMultiparametric Discovery And Optimization PlatformUSPTOUS 11,972,840
Show all 8 patent records
- Multiparametric Discovery And Optimization PlatformSep 18, 2025 · Application 18864951Pending
- Multiparametric Discovery And Optimization PlatformFeb 20, 2025 · Application 18617186Pending
- Multiparametric Discovery And Optimization PlatformApr 30, 2024 · US 11,972,840Granted
- Multiparametric Discovery And Optimization PlatformMar 5, 2024 · US 11,923,045Granted
- Multiparametric Discovery And Optimization PlatformApplication PCTUS2023067263Pending
- Multiparametric Discovery And Optimization PlatformApplication 63343966Pending
- Multiparametric Discovery And Optimization PlatformApplication PCTUS2021059275Pending
- Multiparametric Discovery And Optimization PlatformApplication 63113571Pending
Related companies, and why
- AICONIC BIOSCIENCES LLCSimilar federal contract value in Biotech · null in contracts
- Ray TherapeuticsSimilar federal contract value in Biotech · null in contracts
- NeuBase Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Capacity Bio, Inc.Similar federal contract value in Biotech · null in contracts
- ENTRINSIC HEALTH SOLUTIONS, INC.Similar federal contract value in Biotech · null in contracts
- Vivaldi Biosciences IncSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .